Fernando Vieira

Fernando Vieira

Company: ALS Therapy Development Institute

Job title: CEO and Chief Science Officer


An On-Going ALS Natural History Study to Distinguish Patient Subpopulations & Identify Novel Biomarkers 9:00 am

• Identifying biomarkers to distinguish ALS patient subpopulations for optimized clinical trial recruitment • Connecting biomarkers and target discovery to reveal ALS biology engaged in different subpopulations • Building data to apply approaches for predicting ALS susceptibility and early disease diagnosisRead more

day: Day Two AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.